Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dry Eye Relief Discovered By Sharon Kleyne & Dr. Yuan Fang Of China Combats Global Blindness
  • USA - English

Scientists in China Discover Dry Eye Solution® Nature's Tears® EyeMist® for China. Dr. Yuan Fang & Bio Logic Aqua® Research Founder Sharon Kleyne Bring Long-Lasting Dry Eye Relief to World & China with Nature's Tears® EyeMist®.


News provided by

Bio Logic Aqua Research

Nov 27, 2019, 06:00 ET

Share this article

Share toX

Share this article

Share toX

GRANTS PASS, Ore., Nov. 27, 2019 /PRNewswire-PRWeb/ -- Sixty percent of young people in China are nearsighted and 300 million Chinese people suffer from dry eye disease, says Dr. Yuan Fang, M.A., Ph.D. of the Bio Chemistry Research Center in China.

Joining Sharon Kleyne, founder and research director of Bio Logic Aqua® Research Water Life Science® in Grants Pass, Oregon and the host of the internationally syndicated radio program, The Sharon Kleyne Hour Water Life Science®/Nature's Pharma®, The Power of Water® & Your Health sponsored by Nature's Tears® EyeMist® on VoiceAmerica and produced by Rose Hong, founder and director of Global Dragon TV in Washington, D.C., genome researcher Fang strongly supports the use in China of Kleyne's signature invention to provide long-lasting relief from dry eye, Nature's Tears® EyeMist®.

Dr. Fang is internationally respected for his genome research and efforts to provide relief from dry eye and eye fatigue. After earning a Ph.D. in physiology in China, Fang came to the United States for post-doctoral training in neurology. Fang also studied dry eye at the OHSU Casey Eye Institute in Portland, Oregon where, says Fang, he began to notify and agitate people about the danger of dry eye and other ocular disorders. Fang and colleagues agree that over-evaporation of the tear film can infect and damage the cornea, causing symptoms that include headaches, irritability, exhaustion, red eyes, blurred vision, distracted behavior, poor vision, poor schoolwork, loss of productivity on the job and damage to relationships in families and communities. In severe cases, dry eye can also led to blindness.

Kleyne and Fang call for better education in China and around the world about dry eye, its causes, symptoms and treatments. Fang and Kleyne also want to see more new water technology and research and more proactive, individual care than they see now. "People must take responsibility for their personal health," says Kleyne, inventor of the Health Olympics, a new lifestyle that encourages people everywhere to be responsible about their health care.

Fang and Kleyne encourage everyone to drink 8 to 10 glasses of water every day to replace the body water vapor that is lost continually through the natural process of evaporation. People also must learn to sleep with the earth, getting the rest that they (and their eyes) need every night. Breathing properly is important, too. Yoga, Tai Chi and Qigong teach proper breathing techniques And moderate exercise promotes improved health and well being. Diet should be designed to meet an individual's specific needs because "Everyone is unique," says Kleyne.

Fang and Kleyne are also promoting and teaching the use in China of Nature's Tears® EyeMist®, the world's only Dry Eye Solution® that is more than Just a Mist® or a chemical eye drop. Nature's Tears® EyeMist® consists of pH-balanced, 100 percent Trade Secret tissue culture grade water and applied to the eye with a personal, patented micron-size mist, technology that is designed for ultimate absorption by the eye's tear film, which is naturally 99 percent water. Nature's Tears® EyeMist® new technology is painless and does not blur vision. Nature's Tears® EyeMist® contains no additives or chemicals and is regularly tested in multiple laboratories, and is pure water that is lighter in weight than eye drops. That increased weight speeds up evaporation of the water in the eye.

Date aired: November 25th, 2019
Guest: Dr. Yuan Fang, M.A., Ph.D., China

You may listen to the program featuring Dr. Yuan Fang and Sharon Kleyne discussing dry eye disease, relief of dry eye with Nature's Tears® EyeMist®, education, water evaporation, new water research technology and other ocular issues in China by following this link: https://www.voiceamerica.com/episode/118967/encore-the-dry-eye-population-in-china-and-treatment-options

If you wish to see a brief educational film that demonstrates the application of the new Dry Eye Solution® technology Nature's Tears® EyeMist®, go here: https://www.youtube.com/watch?v=l0gOr8TB45U

SOURCE Bio Logic Aqua Research

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.